Bio-Rad Laboratories, Inc. (BIO) financial statements (2022 and earlier)

Company profile

Business Address 1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547
State of Incorp. DE
Fiscal Year End December 31
SIC 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8709911,115845755839786
Cash and cash equivalents471662661432384456458
Short-term investments399329454413371383329
Restricted cash and investments6666654
Receivables424419393392465372391
Inventory, net of allowances, customer advances and progress billings572622554584595525490
Inventory572622554584595525490
Prepaid expense108911021871469194
Other current assets10111110101211
Total current assets:1,9892,1402,1802,0231,9771,8451,778
Noncurrent Assets
Operating lease, right-of-use asset205202202
Property, plant and equipment491491499509493489438
Long-term investments and receivables14,3879,5614,6382,6561,028831720
Long-term investments14,3879,5614,6382,6561,028831720
Intangible assets, net (including goodwill)601491410353680639710
Goodwill347292264220506477496
Intangible assets, net (excluding goodwill)254199146133174162214
Other noncurrent assets10387807095  
Other undisclosed noncurrent assets     4866
Total noncurrent assets:15,78710,8335,8293,5882,2962,0061,934
TOTAL ASSETS:17,77612,9738,0095,6114,2733,8513,712
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities465420315295347325310
Accounts payable142139107122135133122
Employee-related liabilities277223180144172163158
Taxes payable46572829402829
Deferred revenue514234
Debt144620000
Deferred compensation liability4      
Deferred revenue and credits283130
Other liabilities12813187101127115102
Other undisclosed current liabilities3234954   
Total current liabilities:681632905451503471441
Noncurrent Liabilities
Long-term debt and lease obligation, including:111214439435434436
Finance lease, liability111111
Operating lease, liability176175176
Other undisclosed long-term debt and lease obligation(176)(174)(174)439435434436
Liabilities, other than long-term debt3,3152,369241701405358344
Deferred tax liabilities, net553222223233
Deferred income tax liabilities3,0592,077 
Liability, pension and other postretirement and postemployment benefits749580    
Other liabilities182197161148183135111
Other undisclosed noncurrent liabilities102801,093    
Total noncurrent liabilities:3,4282,4611,3481,140840792780
Total liabilities:4,1093,0932,2541,5911,3431,2641,221
Stockholders' equity
Stockholders' equity attributable to parent, including:13,6679,8805,7554,0202,9302,5872,491
Additional paid in capital442429410394361333300
Accumulated other comprehensive income (loss)(176)282(87)(47)739418382
Retained earnings13,5079,2685,4713,7221,8301,8361,808
Other undisclosed stockholders' equity attributable to parent(106)(100)(38)(49)(0)(0)(0)
Total stockholders' equity:13,6679,8805,7554,0202,9302,5872,491
TOTAL LIABILITIES AND EQUITY:17,77612,9738,0095,6114,2733,8513,712

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues2,9232,5462,3122,2892,1602,0682,019
Revenue, net2,1602,0682,019
Cost of revenue
(Cost of Goods and Services Sold)
(1,282)(1,108)(1,055)(1,066)(973)(930)(898)
Other undisclosed gross profit00(0)0   
Gross profit:1,6411,4381,2571,2231,1871,1381,122
Operating expenses(1,151)(1,027)(1,027)(1,326)(1,071)(1,085)(955)
Operating income (loss):489411230(103)11753167
Nonoperating income242324343101
Foreign currency transaction loss, before tax(3)(2)(2)(3)(9)(5)(10)
Other nonoperating income27242637121511
Interest and debt expense(2)(22)(23)(24)(22)(22)(22)
Other undisclosed income from continuing operations before equity method investments, income taxes 4,4962,031606   
Income from continuing operations before equity method investments, income taxes:5124,9082,2615139842146
Other undisclosed income from continuing operations before income taxes4,926      
Income from continuing operations before income taxes:5,4384,9082,2615139842146
Income tax expense (benefit)(1,192)(1,101)(502)(147)24(13)(33)
Net income available to common stockholders, diluted:4,2463,8061,75936612228113

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income:4,2463,8061,75936612228113
Other comprehensive income (loss)(458)370(40)(106)32136163
Comprehensive income, net of tax, attributable to parent:3,7884,1761,71825944364276

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: